Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 15;6(9):819-24.
doi: 10.7150/jca.12174. eCollection 2015.

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk

Yoon Hee Cho  1 , Lauren E McCullough  2 , Marilie D Gammon  2 , Hui-Chen Wu  3 , Yu-Jing Zhang  3 , Qiao Wang  3 , Xinran Xu  4 , Susan L Teitelbaum  4 , Alfred I Neugut  5 , Jia Chen  6 , Regina M Santella  3
Affiliations

Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk

Yoon Hee Cho et al. J Cancer. .

Abstract

The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk is currently unclear. We determined whether promoter hypermethylation in blood DNA of candidate tumor suppressor genes frequently methylated in breast tumors can be used as a surrogate biomarker for breast cancer risk. Promoter methylation of BRCA1, CDH1 and RARβ was analyzed in WBC DNA from a population-based sample of 1,021 breast cancer patients and 1,036 controls by the MethyLight assay. Gene-specific promoter methylation in the DNA of 569 tumor tissue samples was also analyzed to determine the correlation of methylation levels with blood from the same individual. Hypermethylation of BRCA1 (OR: 1.31; 95% CI: 0.98-1.75) in WBC was associated with an increased risk of breast cancer when positive methylation was defined as ≥0.1% methylated. There was lack of concordance between tumor tissue and paired WBC DNA methylation. These results provide limited support that hypermethylation of BRCA1 in WBC DNA may be useful for determination of breast cancer risk. Additional studies with larger numbers of genes are needed to fully understand the relationship between WBC methylation and breast cancer risk.

Keywords: BRCA1; Breast cancer; Promoter methylation; white blood cell DNA.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: No potential conflicts of interests were disclosed.

References

    1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415–28. - PubMed
    1. Lian ZQ, Wang Q, Li WP, Zhang AQ, Wu L. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels. Int J Oncol. 2012;41(2):629–38. - PubMed
    1. Catteau A, Harris WH, Xu CF, Solomon E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999;18:1957–65. - PubMed
    1. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE. et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res. 2000;60:4346–8. - PubMed
    1. Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R. et al. Endogenous reactivation of the RAR{beta}2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res. 2002;62:2455–61. - PubMed